Psychiatry :: New direction for development of psychotropic drugs
A panel of academic, industry and government representatives, presenting at the ACNP Annual Meeting, concluded that several factors have impeded the development of novel treatments for mental illness, including: incomplete understanding of the impact of mental illness on the brain; continued skepticism of results from animal models for certain disorders, and an outdated paradigm of treatment and the industry preference toward so-called “me-too” drugs.